$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
TAF能有效防止乙肝恶化成肝硬化和肝癌
2025-10-19 11:44:20
Check Details
TAF(韦立得)获得中国国家药品监督管理局批准上市
2025-10-19 11:44:20
Check Details
TAF适合哪些乙肝患者
2025-10-19 11:44:20
Check Details
TAF能减缓乙肝患者骨密度流失
2025-10-19 11:44:20
Check Details
怀孕期间是否可以服用乙肝药物TAF
2025-10-19 11:44:20
Check Details
抗病毒药物TAF治疗乙肝的优势
2025-10-19 11:44:20
Check Details
TAF获批用于治疗12岁以上乙肝患者
2025-10-19 11:44:20
Check Details
乙肝新药替诺福韦二代
2025-10-19 11:44:20
Check Details
乙肝抗病毒药物替诺福韦
2025-10-19 11:44:20
Check Details
TAF较于替诺福韦治疗乙肝疗效更突出
2025-10-19 11:44:20
Check Details
最强乙肝药物TAF
2025-10-19 11:44:20
Check Details
TAF对乙肝患者具有更好的骨骼安全性
2025-10-19 11:44:20
Check Details
1
2
...
5692
5693
5694
5695
5696
5697
5698
...
10242
10243
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Sotorasib Diarrhea in NSCLC: Grading, Loperamide and Dose Adjustment
2
Avatrombopag vs Eltrombopag in ITP: Onset, Dosing Rules and Pre‑Procedure Use
3
Gilteritinib and Differentiation Syndrome in AML: Recognition, Emergency Management and Monitoring
4
Pralsetinib and Hypertension in NSCLC: Risks, Monitoring and Management
5
Tucatinib Overview: HER2-Positive Breast Cancer and RAS Wild-Type Colorectal Cancer Dosing, Brain Metastases Data and Safety
6
FDA Approves Durvalumab Plus Enfortumab Vedotin for Perioperative Treatment of Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
7
Bepirovirsen (Hibsago) Prescribing Information: Indications, Boxed Warnings, Dose Adjustment and Monitoring
8
Avapritinib (Ayvakit) Prescribing Information: Indications, Dosage, Adverse Reactions and Safety Warnings
9
Daraxonrasib Pregnancy, Lactation and Contraception Safety
10
Afatinib Side Effects and Safety Management
11
Capmatinib for MET Exon 14 Non-Small Cell Lung Cancer
12
Ibrutinib for CLL/SLL: Not for Immediate Use at Diagnosis